Federal award
10X GENOMICS, INC.
HT001422C0003
Contract
Obligated and Ceiling
- Obligated (net)
- $3,308,806.41
- Ceiling (potential value, not spending)
- $3,308,806.42
- Current value
- $3,308,806.42
- Gross positive obligations
- $3,841,498.72
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- 10X GENOMICS, INC. · D1NLDEZ14TV5
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- 10X GENOMICS, INC. · D1NLDEZ14TV5
- Awarding agency
- Department of War · sub-agency 97DH · office HT0014
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- Q999 · MEDICAL- OTHER
- Industry (NAICS)
- 621399 · OFFICES OF ALL OTHER MISCELLANEOUS HEALTH PRACTITIONERS
- PIID
- HT001422C0003
- Award type code
- D
- Actions
- 12 · Oct 25, 2021 to Dec 11, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History12
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 11, 2025 | FY2026 | P00012 | D | $371,793.52 | — |
| Feb 12, 2025 | FY2025 | P00010 | C | $818,603.68 | — |
| Sep 11, 2024 | FY2024 | P00009 | G | $0.00 | — |
| Mar 12, 2024 | FY2024 | P00008 | M | $0.00 | — |
| Dec 14, 2023 | FY2024 | P00007 | G | $799,180.80 | — |
| Jul 11, 2023 | FY2023 | P00006 | B | −$317,203.11 | — |
| Mar 22, 2023 | FY2023 | P00005 | M | $334,003.60 | — |
| Dec 14, 2022 | FY2023 | P00004 | G | $756,310.72 | — |
| Jul 15, 2022 | FY2022 | P00003 | M | −$215,489.20 | — |
| Dec 23, 2021 | FY2022 | P00002 | M | $761,606.40 | — |
| Oct 28, 2021 | FY2022 | P00001 | M | $0.00 | — |
| Oct 25, 2021 | FY2022 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.